# Sinovac Life Sciences Co., Ltd. clinical trials: 26 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials with Sinovac Life Sciences Co., Ltd. as lead sponsor, 8 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Sinovac Life Sciences Co., Ltd.: 26 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/sinovac-life-sciences-co-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 8
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 22, 2026 | NCT07832500 | A Lot-to-Lot Consistency Clinical Trial of PCV13 | Sinovac Life Sciences Co., Ltd. | Phase 3 | Not yet recruiting | Pneumococcal Infectious Diseases | 1,125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07832500) |
| June 8, 2026 | NCT07633119 | A Phase Ⅲ Clinical Study of SNA02-48 Injection | Sinovac Life Sciences Co., Ltd. | Phase 3 | Not yet recruiting | Tetanus | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07633119) |
| May 18, 2026 | NCT07593924 | Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days) | Sinovac Life Sciences Co., Ltd. | Phase 3 | Not yet recruiting | Pneumococcal Infectious Diseases | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07593924) |
| April 21, 2026 | NCT07543198 | Clinical Trial of PCV24 in Adults Aged ≥18 Years | Sinovac Life Sciences Co., Ltd. | Phase 1/2 | Completed | Pneumococcal Infectious Disease | 385 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07543198) |
| January 28, 2026 | NCT07374510 | Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate Vaccine | Sinovac Life Sciences Co., Ltd. | Phase 1 | Not yet recruiting | Meningococcal Meningitis | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07374510) |
| December 24, 2025 | NCT07300644 | Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years | Sinovac Life Sciences Co., Ltd. | Phase 2 | Recruiting | Pneumococcal Infectious Disease | 420 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07300644) |
| May 13, 2025 | NCT06967272 | PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells) | Sinovac Life Sciences Co., Ltd. | Phase 2 | Recruiting | Rotavirus Gastroenteritis | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06967272) |
| April 30, 2025 | NCT06950645 | The Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells) | Sinovac Life Sciences Co., Ltd. | Phase 1 | Completed | Rotavirus Gastroenteritis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06950645) |
| April 23, 2025 | NCT06939777 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants | Sinovac Life Sciences Co., Ltd. | Phase 1/2 | Completed | Tetanus | 255 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06939777) |
| January 29, 2025 | NCT06800261 | Clinical Trial of PCV24 in Infants Aged 2-23 Months | Sinovac Life Sciences Co., Ltd. | Phase 1 | Recruiting | Pneumococcal Infectious Disease | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06800261) |
| September 27, 2024 | NCT06617715 | Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine | Sinovac Life Sciences Co., Ltd. | Phase 3 | Recruiting | Pneumococcal Infectious Disease | 3,080 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06617715) |
| August 13, 2024 | NCT06550830 | Clinical Trial of PCV24 in Children Aged 2-17 Years | Sinovac Life Sciences Co., Ltd. | Phase 1 | Completed | Pneumococcal Infectious Disease | 119 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06550830) |
| June 25, 2024 | NCT06474377 | Clinical Trial of PCV24 in Adults | Sinovac Life Sciences Co., Ltd. | Phase 1 | Completed | Pneumococcal Infectious Disease | 170 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06474377) |
| September 22, 2023 | NCT06050460 | SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19 | Sinovac Life Sciences Co., Ltd. | Phase 1 | Unknown | COVID-19 | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06050460) |
| September 22, 2023 | NCT06049940 | Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population | Sinovac Life Sciences Co., Ltd. | Phase 3 | Completed | Tetanus | 1,260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06049940) |
| September 21, 2023 | NCT06048393 | SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People | Sinovac Life Sciences Co., Ltd. | Phase 1 | Unknown | COVID-19 | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06048393) |
| September 21, 2023 | NCT06042764 | SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients | Sinovac Life Sciences Co., Ltd. | Phase 2 | Unknown | Infection of Upper Respiratory Tract Caused by 2019-nCoV | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06042764) |
| December 29, 2022 | NCT05667714 | Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People | Sinovac Life Sciences Co., Ltd. | Not applicable | Unknown | COVID-19 | 2,900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05667714) |
| December 27, 2022 | NCT05664919 | Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations | Sinovac Life Sciences Co., Ltd. | Not applicable | Unknown | COVID-19 | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05664919) |
| June 1, 2022 | NCT05398926 | Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the Elderly | Sinovac Life Sciences Co., Ltd. | Phase 4 | Completed | COVID-19 | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05398926) |
| April 14, 2022 | NCT05329038 | Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine | Sinovac Life Sciences Co., Ltd. | Phase 4 | Unknown | COVID-19 | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05329038) |
| December 21, 2021 | NCT05165966 | Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of... | Sinovac Life Sciences Co., Ltd. | Phase 4 | Completed | COVID-19 | 340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05165966) |
| October 25, 2021 | NCT05092386 | Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine | Sinovac Life Sciences Co., Ltd. | Phase 1 | Completed | Pneumococcal Infections | 310 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05092386) |
| August 5, 2021 | NCT04992208 | Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents | Sinovac Life Sciences Co., Ltd. | Phase 4 | Completed | COVID-19 | 31,041 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04992208) |
| May 13, 2021 | NCT04884685 | Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents | Sinovac Life Sciences Co., Ltd. | Phase 2 | Completed | COVID-19 | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04884685) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 8 |
| Phase 1/2 | 3 |
| Phase 2 | 4 |
| Phase 3 | 5 |
| Phase 4 | 4 |
| Not applicable | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 12 |
| Unknown | 6 |
| Recruiting | 4 |
| Not yet recruiting | 4 |

## Conditions

| Condition group | Trials |
| --- | --- |
| COVID-19 | 10 |
| Pneumococcal Infections | 7 |
| Tetanus | 3 |
| Meningitis, Meningococcal | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Flooring contractors in the United States](https://specstream.ai/data/businesses/flooring-contractors/united-states)
- [Pan Asian restaurants in the United States](https://specstream.ai/data/businesses/pan-asian-restaurants/united-states)
- [Waste collection companies in the United States](https://specstream.ai/data/businesses/waste-collection-companies/united-states)
- [Countertop installers in the United States](https://specstream.ai/data/businesses/countertop-installers/united-states)
- [Kitchen remodelers in the United States](https://specstream.ai/data/businesses/kitchen-remodelers/united-states)
- [Shipping and delivery companies in the United States](https://specstream.ai/data/businesses/shipping-and-delivery-companies/united-states)
